PTC Therapeutics, Inc. (PTCT)
NASDAQ: PTCT · Real-Time Price · USD
74.68
+2.32 (3.21%)
At close: Feb 6, 2026, 4:00 PM EST
76.39
+1.71 (2.29%)
After-hours: Feb 6, 2026, 6:59 PM EST

PTC Therapeutics Stock Forecast

Stock Price Forecast

The 18 analysts that cover PTC Therapeutics stock have a consensus rating of "Buy" and an average price target of $76.28, which forecasts a 2.14% increase in the stock price over the next year. The lowest target is $45 and the highest is $119.

Price Target: $76.28 (+2.14%)
Analyst Consensus: Buy
TargetLowAverageMedianHigh
Price$45$76.28$75$119
Change-39.74%+2.14%+0.43%+59.35%

Analyst Ratings

The average analyst rating for PTC Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

RatingSep '25Oct '25Nov '25Dec '25Jan '26Feb '26
Strong Buy344444
Buy667677
Hold334555
Sell000000
Strong Sell222222
Total141517171818

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Barclays
Barclays
Buy
Upgrades
$68$119
BuyUpgrades$68$119+59.35%Jan 28, 2026
RBC Capital
RBC Capital
Hold
Downgrades
$82$91
HoldDowngrades$82$91+21.85%Dec 1, 2025
Barclays
Barclays
Hold
Maintains
$46$68
HoldMaintains$46$68-8.94%Nov 6, 2025
Citigroup
Citigroup
Hold
Maintains
$50$75
HoldMaintains$50$75+0.43%Nov 5, 2025
TD Cowen
TD Cowen
Hold
Maintains
$50$63
HoldMaintains$50$63-15.64%Nov 5, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
1.87B
from 806.78M
Increased by 132.16%
Revenue Next Year
978.77M
from 1.87B
Decreased by -47.74%
EPS This Year
9.83
from -4.73
EPS Next Year
-1.08
from 9.83
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
380.77M538.59M698.80M937.82M806.78M1.87B978.77M
Revenue Growth
24.04%41.45%29.75%34.20%-13.97%132.16%-47.74%
EPS
-6.64-7.43-7.79-8.37-4.739.83-1.08
EPS Growth
-------
Forward PE
-----7.60-
No. Analysts
-----1717
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue202520262027202820292030
High2.2B1.2B
Avg1.9B978.8M
Low1.7B689.1M

Revenue Growth

Revenue Growth202520262027202820292030
High
168.0%
-33.8%
Avg
132.2%
-47.7%
Low
113.9%
-63.2%

EPS Forecast

EPS202520262027202820292030
High11.761.31
Avg9.83-1.08
Low8.56-3.41

EPS Growth

EPS Growth202520262027202820292030
High-
-86.6%
Avg--
Low--
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.